1

This phase was discontinued when 36% (8 patients on HD, PD, or post-transplant) reported an adverse event (hypotension, nausea, vomiting, low back pain, bilateral edema). A dose of 300 mg (diluted in 250 ml 0.9% NaCl) over 3 hours (n=189) was then evaluated without reports of adverse events. ................
................